[1]马旭莲,朱芳一,祝存奎,等.青海地区心力衰竭患者的双心医学调查及其影响因素研究[J].医学信息,2023,36(12):70-73.[doi:10.3969/j.issn.1006-1959.2023.12.013]
　MA Xu-lian,ZHU Fang-yi,ZHU Cun-kui,et al.Investigation of Psycho-cardiology and its Influencing Factors in Patients with Heart Failure in Qinghai Area[J].Journal of Medical Information,2023,36(12):70-73.[doi:10.3969/j.issn.1006-1959.2023.12.013]
点击复制

青海地区心力衰竭患者的双心医学调查及其影响因素研究()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
36卷
期数:
2023年12期
页码:
70-73
栏目:
公共卫生信息学
出版日期:
2023-06-15

文章信息/Info

Title:
Investigation of Psycho-cardiology and its Influencing Factors in Patients with Heart Failure in Qinghai Area
文章编号:
1006-1959（2023）12-0070-04
作者:
马旭莲; 朱芳一; 祝存奎; 等
（青海省心脑血管病专科医院心律失常二科及心力衰竭科，青海 西宁 810099）
Author(s):
MA Xu-lian; ZHU Fang-yi; ZHU Cun-kui; et al.
(The Second Department of Arrhythmias and Department of Heart Failure,Qinghai Provincial Cardiovascular andCerebrovascular Disease Specialist Hospital,Xining 810099,Qinghai,China)
关键词:
心力衰竭; 双心医学; 青海地区; 抑郁; 心功能
Keywords:
Heart failure; Psycho-cardiology; Qinghai area; Depression; Cardiac function
分类号:
R541.6
DOI:
10.3969/j.issn.1006-1959.2023.12.013
文献标志码:
A
摘要:
目的 研究青海地区心力衰竭（HF）患者双心医学的相关影响因素。方法 以2020年1月-2022年1月青海省心脑血管病专科医院收治的80例HF患者为研究对象，分析心脏疾病及心理疾患情况，HF合并抑郁障碍的危险因素。结果 患者NYHA分级集中在Ⅱ级、Ⅲ级、Ⅳ级，共有58.75%（47/80）患者合并抑郁障碍，其中以轻、中度抑郁最为常见。单因素分析显示，HF合并抑郁障碍者与HF未合并抑郁障碍者性别、年龄、受教育程度、NYHA分级、RAS抑制剂使用情况比较，差异有统计学意义（P＜0.05）；多因素Logistic分析发现，女性、年龄≥60岁、NYHA分级升高是HF合并抑郁障碍的独立危险因素，使用RAS抑制剂是HF合并抑郁障碍的保护因素（P＜0.05）。结论 HF患者合并抑郁障碍的比例较高，其中性别、年龄、NYHA分级、RAS抑制剂均为HF患者双心医学的影响因素。
Abstract:
Objective To study the related factors of psycho-cardiology in patients with heart failure(HF) in Qinghai area.Methods From January 2020 to January 2022, 80 patients with HF admitted to Qinghai Provincial Cardiovascular and Cerebrovascular Disease Specialist Hospital were selected as the research objects. The heart disease and psychological disorders, and the risk factors of HF combined with depressive disorder were analyzed.Results The NYHA classification of patients was concentrated in grade Ⅱ, grade Ⅲ and grade Ⅳ. A total of 58.75%(47/80) patients had depressive disorder, of which mild and moderate depression was the most common. Univariate analysis showed that there were significant differences in gender, age, education level, NYHA classification and RAS inhibitor use between HF patients with depression and HF patients without depression (P<0.05). Multivariate logistic analysis showed that female, age≥60 years old, and elevated NYHA classification were independent risk factors for HF with depressive disorder, and the use of RAS inhibitors was a protective factor for HF with depressive disorder (P<0.05).Conclusion The proportion of HF patients with depressive disorder is higher, and gender, age, NYHA classification and RAS inhibitors are the influencing factors of psycho-cardiology in HF patients.

参考文献/References:

[1]任芳芳.慢性心力衰竭患者心脏再同步治疗（CRT）术后出现抑郁焦虑障碍的影响因素及对预后的影响[J].国际精神病学杂志,2019,46(6):1089-1091,1098.[2]樊欣娜,李萍,陈金良,等.慢性心力衰竭患者心身症状综合征、焦虑抑郁状态和影响因素分析[J].中国循证心血管医学杂志,2022,14(1):42-45.[3]Gathright EC,Goldstein CM,Josephson RA,et al.Depression increases the risk of mortality in patients with heart failure:A meta-analysis[J].J Psychosom Res,2017,94:82-89.[4]Arifin Y,Saifur RM,Tjahjono CT,et al.OR22.Correlation Between the New York Heart Association Functional Class with depression in Heart Failure patients: A Cross sectional study[J].European Heart Journal Supplements,2021,23(Supplement_F):122.[5]中华医学会心血管病学分会心力衰竭学组,中国医师协会心力衰竭专业委员会,中华心血管病杂志编辑委员会.中国心力衰竭诊断和治疗指南2018[J].中华心血管病杂志,2018,46(10):760-789.[6]张琦,夏丽莉.老年慢性心力衰竭住院病人抑郁状态及相关因素分析[J].实用老年医学,2020,34(8):848-851.[7]De Vecchis R,Manginas A,Noutsias E,et al.Comorbidity "depression" in heart failure - Potential target of patient education and self-management[J].BMC Cardiovasc Disord,2017,17(1):48.[8]姚光琳.双心医学模式对慢性心力衰竭伴焦虑抑郁状态患者心率变异性及心功能的影响[J].中国健康心理学杂志,2019,27(5):723-727.[9]饶芳,瓦哈甫.新疆喀什地区维吾尔族慢性心力衰竭住院病人抑郁、焦虑的调查研究[J].中西医结合心脑血管病杂志,2019,17(9):1367-1370.[10]潘丽红,王继军,徐林群,等.心力衰竭患者抑郁状况及相关因素[J].国际精神病学杂志,2019,46(3):431-434.[11]张青,田晶,任嘉,等.基于患者报告结局的慢性心力衰竭病人抑郁影响因素分析[J].中西医结合心脑血管病杂志,2021,19(6):909-912,918.[12]陈黎明,刘晶,张婧,等.慢性心力衰竭患者认知情绪调节、生活质量与焦虑抑郁的研究[J].中国循环杂志,2017,32(10):956-959.[13]Hassan R,Riehl-Tonn VJ,Dumanski SM,et al.Female sex-specific and -predominant cardiovascular risk factors and heart failure practice guidelines[J].Am Heart J,2022,247:63-67.[14]尹玥,王代梅,党永霞.老年慢性心力衰竭患者抑郁症状严重程度与社会支持的相关性及其影响因素[J].中国健康心理学杂志,2019,27(4):566-570.[15]Gori M,Marini M,De Maria R,et al.Italian Network on Heart Failure (IN-HF) Investigators. Age-related changes in clinical characteristics and outcomes of chronic heart failure outpatients in a cardiology setting. A report from the Italian Network on Heart Failure[J].Int J Cardiol,2022,346:36-44.[16]毛毅,肖进群,陈思洁,等.慢性心力衰竭患者并发抑郁障碍的影响因素及对患者UA、CysC、Scr、生活质量及预后的影响[J].现代生物医学进展,2022,22(11):2123-2127.[17]高敏,胡丹丽,邢福威,等.心力衰竭患者抑郁及其与一年结局的相关性分析[J].中国循环杂志,2021,36(6):606-611.[18]Yin H,Liu Y,Ma H,et al.Associations of mood symptoms with NYHA functional classes in angina pectoris patients: a cross-sectional study[J].BMC Psychiatry,2019,19(1):85.[19]Vian J,Pereira C,Chavarria V,et al.The renin-angiotensin system: a possible new target for depression[J].BMC Med,2017,15(1):144.[20]刘圆圆,杜昕,何柳,等.慢性射血分数减低的心力衰竭合并肾功能不全患者血管紧张素转化酶抑制剂/受体阻滞剂应用的影响因素分析[J].心肺血管病杂志,2019,38(1):14-17.[21]K?觟hler-Forsberg O,Petersen L,Berk M,et al.he effect of combined treatment with SSRIs and renin-angiotensin system (RAS) drugs: A propensity score matched cohort study[J].Eur Neuropsychopharmacol,2020,32:120-130.[22]梁玉兰,吕晓珍,张莹,等.住院老年心力衰竭患者抑郁障碍患病状况及影响因素初步分析[J].心肺血管病杂志,2019,38(5):476-479.

相似文献/References:

[1]郭俊林,张立.BNP对CRT后期疗效的临床评价[J].医学信息,2018,31(01):67.[doi:10.3969/j.issn.1006-1959.2018.01.024]
　GUO Jun-lin,ZHANG li.Clinical Evaluation of BNP in Treatment of Late CRT[J].Journal of Medical Information,2018,31(12):67.[doi:10.3969/j.issn.1006-1959.2018.01.024]
[2]张发艳.双心医学的研究进展[J].医学信息,2018,31(06):48.[doi:10.3969/j.issn.1006-1959.2018.06.016]
　ZHANG Fa-yan.Research Progress of Double Heart Medicine[J].Journal of Medical Information,2018,31(12):48.[doi:10.3969/j.issn.1006-1959.2018.06.016]
[3]程 林.重组人脑利钠肽用于重症急性心肌炎伴 心力衰竭患者治疗的临床研究[J].医学信息,2018,31(08):126.[doi:10.3969/j.issn.1006-1959.2018.08.042]
　CHENG Lin.Clinical Study of Recombinant Human Brain Natriuretic Peptide in the Treatment of Patients with Severe Acute Myocarditis and Heart Failure[J].Journal of Medical Information,2018,31(12):126.[doi:10.3969/j.issn.1006-1959.2018.08.042]
[4]胡丽君.螺内酯联合曲美他嗪治疗慢性心力衰竭的疗效分析[J].医学信息,2018,31(08):131.[doi:10.3969/j.issn.1006-1959.2018.08.044]
　HU Li-jun.Efficacy of Spironolactone Combined with Trimetazidine in the Treatment of Chronic Heart Failure[J].Journal of Medical Information,2018,31(12):131.[doi:10.3969/j.issn.1006-1959.2018.08.044]
[5]李 铎,王建华.盐酸曲美他嗪片辅助治疗对冠心病伴心力衰竭患者氧化应激、心肌功能的影响[J].医学信息,2018,31(10):126.[doi:10.3969/j.issn.1006-1959.2018.10.041]
　LI Duo,WANG Jian-hua.Effect of Trimetazidine Hydrochloride Tablets Adjuvant Therapy on Oxidative Stress and Myocardial Function in Patients with Coronary Heart Disease Complicated with Heart Failure[J].Journal of Medical Information,2018,31(12):126.[doi:10.3969/j.issn.1006-1959.2018.10.041]
[6]何玲玲,程淑芬.曲美他嗪联合琥珀酸美托洛尔治疗冠心病心力衰竭疗效观察[J].医学信息,2018,31(13):142.[doi:10.3969/j.issn.1006-1959.2018.13.042]
　HE Ling-ling,CHENG Shu-fen.Therapeutic Effect of Trimetazidine Combined with Metoprolol Succinate in the Treatment of Coronary Heart Disease with Heart Failure[J].Journal of Medical Information,2018,31(12):142.[doi:10.3969/j.issn.1006-1959.2018.13.042]
[7]赵 维,廖荣宏,王爱华.糖皮质激素治疗心力衰竭疗效与安全性的Meta分析[J].医学信息,2018,31(14):70.[doi:10.3969/j.issn.1006-1959.2018.14.021]
　ZHAO Wei,LIAO Rong-hong,WANG Ai-hua.Meta-analysis of the Efficacy and Safety of Glucocorticoids in the Treatment of Heart Failure[J].Journal of Medical Information,2018,31(12):70.[doi:10.3969/j.issn.1006-1959.2018.14.021]
[8]施国富,吴春阳,施亚明,等.血浆脑钠肽对射血分数保留心力衰竭患者的诊断价值研究[J].医学信息,2018,31(16):47.[doi:10.3969/j.issn.1006-1959.2018.16.013]
　SHI Guo-fu,WU Chun-yang,SHI Ya-ming,et al.Diagnostic Value of Plasma Brain Natriuretic Peptide in Patients with Heart Failure Preserved by Ejection Fraction[J].Journal of Medical Information,2018,31(12):47.[doi:10.3969/j.issn.1006-1959.2018.16.013]
[9]李 宁,胡硕强.心脏再同步治疗心力衰竭的文献计量分析[J].医学信息,2018,31(19):79.[doi:10.3969/j.issn.1006-1959.2018.19.024]
　LI Ning,HU Shou-qiang.Bibliometric Analysis of Cardiac Resynchronization in the Treatment of Heart Failure[J].Journal of Medical Information,2018,31(12):79.[doi:10.3969/j.issn.1006-1959.2018.19.024]
[10]颜 琼,王 静,胡 聪.慢性心力衰竭患者半年内重返住院的调查分析与对策[J].医学信息,2018,31(20):173.[doi:10.3969/j.issn.1006-1959.2018.20.055]
　YAN Qiong,WANG Jing,HU Cong.Investigation and Countermeasures of Patients with Chronic Heart Failure Returning to Hospital within Half a Year[J].Journal of Medical Information,2018,31(12):173.[doi:10.3969/j.issn.1006-1959.2018.20.055]

更新日期/Last Update: 1900-01-01